A 68-Year-Old Man with Proximal Weakness and Seizures
Neurol 97:e423-e428, Chen, T., 2021
Long-Term Follow-Up, Quality of Life, and Survival of Patients with Lambert-Eaton Myasthenic Syndrome
Neurol 94:e511-e520, Lipka, A.F.,et al, 2020
Drug Approved for Rare Muscle Weakening Syndrome
JAMA 321:239, Voelker, R., 2019
Paraneoplastic Neurologic Disorders in Small Cell Lung Carcinoma
Neurol 85:235-239, Gozzard, P.,et al, 2015
Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014
Diagnosis of Lambert-Eaton Myasthenic Syndrome in Children
Neurol 80:e220-e222, Morgan-Followell,B.& de los Reyes,E., 2013
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011
SOX1 Antibodies Are Markers of Paraneoplastic Lambert-Eaton Myasthenic Syndrome
Neurol 70:924-928, Sabater,L.,et al, 2008
Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Lambert-Eaton Myasthenic Syndrome Associated With Thymitis
Neurol 64:168-169, Warren,N.M.,et al, 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Paraneoplastic Syndromes Involving the Nervous System
NEJM 349:1543-1554, Darnell,R.B. &Posner,J.B., 2003
Difference in Distribution of Muscle Weakness Between Myasthenia Gravis and the Lambert-Eaton Myasthenic Syndrome
JNNP 73:766-768, Wirtz,P.W.,et al, 2002
Seronegative Lambert-Eaton Myasthenic Syndrome
Neurol 59:1773-1775, Nakao,Y.K.,et al, 2002
Brain Stem Compression by a Giant Vertebrobasilar Aneurysm Mimicking Seronegative Myasthenia
JNNP 71:125-126, Frisby,J.,et al, 2001
A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Neurol 54:603-607, Sanders,D.B.,et al, 2000
Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999
Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Acetylcholine Receptor Antibodies in the Lambert-Eaton Myasthenic Syndrome
Neurol 50:470-475, Katz,J.S.,et al, 1998
Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Calcium Channels in Neurological Disease
Ann Neurol 42:275-282, Greenberg,D.A., 1997
Effects of Intravenous Immunoglobulin on Muscle Weakness & Calcium-Channel Autoantibodies in Lambert-Eaton Myasthenic Synd
Neurol 47:678-683, Bain,P.G.,et al, 1996
Acute Ventilatory Failure in Lambert-Eaton Myasthenic Syndrome and Its Response to 3, 4-Diaminopyridine
Neurol 46:1143-1145, Smith,A.&Wald,J., 1996
Lambert-Eaton Myasthenic Syndrome Presenting with Severe Respiratory Failure
Muscle & Nerve 19:1328-1333996., Nicolle,M.W.,et al, 1996
Lambert-Eaton Myasthenic Syndrome (LEMS) in Association with Lymphoproliferative Disorders
Muscle & Nerve 18:715-719995., Argov,Z.,et al, 1995
Calcium-Channel Antibodies in the Lambert-Eaton Syndrome and Other Paraneoplastic Syndromes
NEJM 332:1467-1474, Lennon,V.A.,et al, 1995
Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340, LeForestier,N.,et al, 1995
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Clinicopath Conf
Small Cell CA (of lung) with Lambert-Eaton Myasthenic Syndr, Case 32-1994, NEJM 331:528-5354., , 1994
Reversal of Subacute Paraneoplastic Cerebellar Syndrome with Intravenous Immunoglobulin
Neurol 44:1184-1185, Counsell,C.E.,et al, 1994
Clinical and Electrophysiologic Improvement in Lambert-Eaton Syndrome with Intravenous Immunoglobulin Therapy
Neurol 42:1422-1423, Bird,S.J., 1992
Trends in the Association of Lambert-Eaton Myasthenic Syndrome with Carcinoma
Neurol 42:848-850, Gutmann,L.,et al, 1992
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Calcium Channel Autoantibodies in the Lambert-Eaton Myashenic Syndrome
Ann Neurol 29:307-314, Leys,K.,et al, 1991
Neurological Paraneoplastic Syndromes in Patients with Small Cell Lung Cancer, A Prospective Survey of 150 Pts
JNNP 54:764-767, Elrington,G.M.,et al, 1991
Edrophonium Responsiveness not Necessarily Diagnostic of Myasthenia Gravis
Muscle & Nerve 13:187-191990., Oh,S.J.&Cho,H.K., 1990
Response of the Lambert-Eaton Myasthenic Syndrome to Treatment of Associated Small-Cell Lung Carcinoma
Neurol 40:1552-1556, Chalk,C.H.,et al, 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
3, 4-Diaminopyridine in the Treatment of Lambert-Eaton Myasthenic Syndrome
NEJM 321:1567-1571, 1607-16081989., McEvoy,K.M.,et al, 1989
Specificity of Calcium Channel Autoantibodies in Lambert-Eaton Myasthenic Syndrome
Lancet 2:640-643, Sher,E.,et al, 1989
The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989
Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
The Lambert-Eaton Myasthenic Syndrome, A Review of 50 Cases
Brain 111, 577-5961988., O'Neill,J.H.,et al, 1988